# Metabolic Effects of Melatonin in Patients Treated With Second Generation Antipsychotics

> **NCT01811160** · PHASE4 · COMPLETED · sponsor: **Instituto Nacional de Psiquiatría Dr. Ramón de la Fuente** · enrollment: 50 (actual)

## Conditions studied

- Second Generation Antipsychotic Induced Metabolic Adverse Effects

## Interventions

- **DRUG:** Melatonin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01811160
- **Lead sponsor:** Instituto Nacional de Psiquiatría Dr. Ramón de la Fuente
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2013-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01811160

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01811160, "Metabolic Effects of Melatonin in Patients Treated With Second Generation Antipsychotics". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01811160. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*